REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal® for Spinocerebellar Ataxia (SCA3 and SCA6)

REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product Stemchymal®, for which the company holds ...
Finanznachrichten

REPROCELL Inc.: REPROCELL Submits Application for Manufacturing and Marketing Approval in Japan for Stem Cell Therapy Stemchymal for Spinocerebellar Ataxia (SCA3 and SCA6)

YOKOHAMA, Japan, June 24, 2026 /PRNewswire/ -- REPROCELL Inc. today announced the submission of an application for manufacturing and marketing approval in Japan for the regenerative medicine product ...
Le Lézard

AstraZeneca and YMCA of the USA Announce Landmark Partnership Aimed to Address Gaps in Cancer Care

AstraZeneca and YMCA of the USA (Y-USA) announced today at the Aspen Ideas: Health conference, a five-year partnership focused on strengthening cancer education in the areas of screening and early ...
note

[June 25] List of Stocks Hitting Daily Limit High and Explanation of Reasons | Including Volume Surges and Upward Revisions

Today's Tokyo stock market saw a significant rebound, with the Nikkei Stock Average rising by over 2,900 yen at one point compared to the previous day, driven by the strong tailwind of record-breaking ...
marketbeat

Sarepta Therapeutics (SRPT) FDA Approvals

Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more. This section ...
LinkedIn

National Ataxia Foundation

The National Ataxia Foundation is a membership supported nonprofit organization established in 1957 to help persons with Ataxia and their families. NAF's primary purpose is to support promising Ataxia ...